切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2020, Vol. 14 ›› Issue (03) : 129 -132. doi: 10.11817/j.issn.1673-9248.2020.03.002

所属专题: 专家论坛 文献

专家论坛

颈动脉支架置入术后脑高灌注综合征的临床研究现状及进展
姚东陂1, 缪中荣2,()   
  1. 1. 100070 首都医科大学附属北京天坛医院神经介入中心,100122 北京朝阳中西医结合急诊抢救中心神经内二科
    2. 100070 首都医科大学附属北京天坛医院神经介入中心
  • 收稿日期:2020-03-19 出版日期:2020-06-01
  • 通信作者: 缪中荣

Clinical research status and progress on cerebral hyperperfusion syndrome after carotid stenting

Dongpo Yao1, Zhongrong Miao2,()   

  1. 1. Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China, Department of Neurology, Beijing Chaoyang Integrative Medicine Emergency Medical Center, Beijing 100122, China
    2. Department of Interventional Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
  • Received:2020-03-19 Published:2020-06-01
  • Corresponding author: Zhongrong Miao
  • About author:
    Corresponding author: Miao Zhongrong, Email:
引用本文:

姚东陂, 缪中荣. 颈动脉支架置入术后脑高灌注综合征的临床研究现状及进展[J]. 中华脑血管病杂志(电子版), 2020, 14(03): 129-132.

Dongpo Yao, Zhongrong Miao. Clinical research status and progress on cerebral hyperperfusion syndrome after carotid stenting[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2020, 14(03): 129-132.

症状性颈动脉狭窄是脑卒中的重要病因,针对其治疗的颈动脉支架置入术(CAS)目前已在临床普遍开展。脑高灌注综合征(CHS)是CAS术后的严重并发症之一。本文将对CAS术后CHS的流行病学特点、发病机制、危险因素、临床表现、辅助检查、诊断及其预防治疗的研究现状及进展进行综述,以指导临床实践。

Symptomatic carotid stenosis is a major cause of stroke, and carotid artery stenting (CAS) has been widely used in clinical practice. Cerebral hyperperfusion syndrome (CHS) is a severe complication post CAS. This review covers the current status and progress of CHS after CAS, including the epidemiology, pathogenesis, risk factors, clinical manifestations, assistant examination, diagnosis, prevention, and treatment, in order to guide clinical practice.

1
王荣耀, 王勇. 颈动脉狭窄行颈动脉内膜切除术后应用不同剂量阿司匹林效果及安全性分析 [J]. 中国临床医生杂志, 2018, 46(01): 75-77.
2
贾子昌, 卞焕菊, 韩金涛, 等. 颈动脉支架成形术后脑高灌注综合征 [J]. 北京大学学报(医学版), 2019, 51(04): 733-736.
3
Zhang Y, Kumar A, Tezel JB, et al. Imaging Evidence for Cerebral Hyperperfusion Syndrome after Intravenous TissuePlasminogen Activator for Acute Ischemic Stroke [J]. Case Rep Neurol Med, 2016, 2016: 8725494.
4
李宝民, 缪中荣, 王拥军, 等. 症状性颅内动脉粥样硬化性狭窄血管内治疗中国专家共识2018 [J]. 中国卒中杂志, 2018, 13(06): 594-604.
5
Galyfos G, Sianou A, Filis K. Cerebral hyperperfusion syndrome and intracranial hemorrhage after carotid endarterectomy or carotid stenting:ameta-analysis [J]. J Neurol Sci, 2017, 381: 74-82.
6
González García A, Moniche F, Escudero-Martínez I, et al. Clinical predictors of hyperperfusion syndrome following carotid stenting: Results From a National Prospective Multicenter Study [J]. JACC Cardiovasc Interv, 2019, 12(09): 873-882.
7
邱永逸, 陈劲草, 章剑剑, 等. 成人烟雾病STA-MCA分流术联合EMS后脑出血和高灌注综合征的关系 [J]. 中国临床神经外科杂志, 2019, 24(07): 387-389.
8
Andereggen L, Amin-Hanjani S, El-Koussy M, et al. Quantitative magnetic resonance angiography as a potential predictor for cerebral hyperperfusion syndrome: a preliminary study [J]. J Neurosurg, 2017, 128(04): 1-9.
9
Nomura S, Yamaguchi K, Ishikawa T, et al. Factors of delayed hyperperfusion and the importance of repeated cerebral blood flow evaluation for hyperperfusion after direct bypass for Moyamoya Disease [J]. World Neurosurg, 2018, 118: e468-e472.
10
Ishikawa T, Yamaguchi K, Kawashima A, et al. Predicting the occurrence of hemorrhagic cerebral hyperperfusion syndrome using regional cerebral blood flow after direct bypass surgery in patients with Moyamoya Disease [J]. World Neurosurg, 2018, 119: e750-e756.
11
Kneihsl M, Niederkorn K, Deutschmann H, et al. Increased middle cerebral artery mean blood flow velocity index after stroke thrombectomy indicate increased risk for intracranial hemorrhage [J]. J Neurointerv Surg, 2018, 10(09): 882-887.
12
Yamamoto D, Hosoda K, Uchihashi Y, et al. Perioperative changes in cerebral perfusion territories assessed by arterial spin labeling magnetic resonance imaging are associated with postoperative increases in cerebral blood flow in patients with carotid stenosis [J]. World Neurosurg, 2017, 102(06): 477-486.
13
Medel R, Crowley RW, Dumont AS. Hyperperfusion syndrome following endovascular cerebral revascularization [J]. Neurosurg Focus, 2009, 26(03): E4.
14
陆培琴, 洪丽燕, 王双虎, 等. 预防性安置临时起搏器对颈动脉支架植入术病人颈动脉窦反应及并发症的影响 [J]. 中西医结合心脑血管病杂志, 2018, 16(13): 1938-1940.
15
Hashimoto T, Matsumoto S, Ando M, et al. Cerebral hyperperfusion syndrome after endovascular reperfusion therapy in a patient with acute internal carotid artery and middle cerebral artery occlusions [J]. World Neurosurg, 2018, 110: 145-151.
16
方运勇, 王亚, 梁福晓, 等. 磁共振成像用于高灌注性脑病临床诊断的表现及特征研究 [J]. 中国医学工程, 2018, 26(09): 9-11.
17
李颜, 白小欣, 蔡军. 颈内动脉支架成形术后高灌注综合征3例分析 [J]. 中西医结合心脑血管病杂志, 2018, 16(09): 1308-1309.
18
Wang SB, Han J, Cheng L, et al. Risk factors and preventive measures of cerebral hyperperfusion syndrome after carotid artery interventional therapy [J]. Exp Ther Med, 2017, 14(03): 2517-2520.
19
Wang GJ, Beck AW, De Martino RR. Insight into the cerebral hyperperfusion syndrome following carotid endarterectomy from the national Vascular Quality Initiative [J]. J Vasc Surg, 2017, 65(02): 381-389.
20
Hussain MA, Alali AS, Mamdani M, et al. Risk of intracranial hemorrhage after carotid artery stenting versus endarterectomy: a population-based study [J]. J Neurosurg, 2018, 129(06): 1-8.
21
柳雅洁, 袁军. 经颅多普勒超声在评估与诊断血管再通后脑高灌注综合征的应用 [J].内蒙古医学杂志, 2019, 51(08): 950-952.
22
郭京华, 唐守现, 彭伟, 等. 缺血性脑血管病患者FLAIR血管高信号征三种评分方法的一致性研究 [J]. 磁共振成像, 2018, 09(05): 340-345.
23
李桥, 高心逸, 胡海梦. CT灌注成像评价急性缺血性脑梗死患者侧支循环变化 [J]. 中国临床神经科学, 2018, 26(04): 374-382.
24
Tseng YC, Hsu HL, Lee TH, et al. Prediction of cerebral hyperperfusion syndrome after carotid stenting: a cerebral perfusion computed tomography study [J]. J Comput Assist Tomogr, 2009, 33(04): 540-545.
25
Park HS, Nakagawa I, Yokoyama S, et al. Amplitude of tissue oxygenation index change predicts cerebralhyperperfusion syndrome during carotid artery stenting [J]. World Neurosurg, 2017, 99: 548-555.
26
Misaki K, Uchiyama N, Inaki A, et al. Objective evaluation of cerebrovascular reactivity for acetazolamide predicts cerebral hyperperfusion after carotid artery stenting:comparison with region of interest methods [J]. J Neuroradiol, 2018, 45(06): 362-367.
27
Yamauchi K, Enomoto Y, Otani K, et al. Prediction of hyperperfusion phenomenon after carotid artery stenting and carotid angioplasty using quantitative DSA with cerebral circulation time imaging [J]. J Neurointerv Surg, 2018, 10(06): 576-579.
28
Leslie-Mazwi T, Chen M, Yi J, et al. Post-thrombectomy management Of the ELVO patient: Guidelines from the Society of Neuro Interventional Surgery [J]. J Neurointerv Surg, 2017, 09(12): 1258-1266.
29
Abou-Chebl A,Reginelli J,Bajzer CT,et al. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting [J]. Catheter Cardiovasc Interv,2007,69(05): 690-696.
30
Kirchoff-Torres KF, Bakradze E. Cerebral hyperperfusion syndrome after carotid revascularization and acute ischemic stroke [J]. Curr Pain Headache Rep, 2018, 22(04): 24.
31
Nair AS. Benefits of using dexmedetomidine during carotid endarterectomy: A review [J]. Saudi J Anaesth, 2014, 08(02): 264-267.
32
Milgrom D, Hajibandeh S, Hajibandeh S, et al. Editor’s choice dystematic review and meta-analysis of very urgent carotidintervention for symptomatic carotid disease [J]. Eur J Vasc Endovasc Surg, 2018, 56(05): 622-631.
33
Wu F, Huang L, Lu G, et al. Two-stage cerebral hemodynamic changes in staged carotid angioplasty and stenting [J]. J Stroke Cerebrovasc Dis, 2016, 25(12): 2814-2820.
34
Uchida K, Yoshimura S, Shirakawa M, et al. Experience of staged angioplasty to avoid hyperperfusion syndrome for carotid artery stenosis [J]. Neurol Med Chir (Tokyo), 2015, 55(11): 824-829.
35
刘文静, 黄照河, 郭灿收, 等. 多发颅内外动脉狭窄支架植入术后脑高灌注综合征一例 [J]. 右江民族医学院学报, 2018, 40(02): 182-184.
36
Farooq MU, Goshgarian C, Min J, et al. Pathophysiology and management of reperfusion injury and hyperperfusion syndrome after carotid endarterectomy and carotid artery stenting [J]. Exp Transl Stroke Med, 2016, 08(01): 7.
37
Matano F, Murai Y, Mizunari T, et al. Intracerebral hemorrhagecaused by cerebral hyperperfusion after superficial temporal artery to middle cerebral artery bypass for atherosclerotic occlusive cerebrovascular disease [J]. NMC Case Rep J, 2016, 04(01): 27-32.
[1] 戴云, 徐超丽, 林秀玉, 孙晖, 李娟, 宋秋怡, 王晓春, 杨斌. 超声造影评价移植肾动脉狭窄支架治疗短期疗效的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(03): 301-306.
[2] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[3] 樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[4] 汪沛, 倪蓓君, 元及, 宫为一, 范军. 卡瑞利珠单抗联合卡铂和培美曲塞治疗进展期肺腺癌的疗效及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 511-513.
[5] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[6] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[7] 龙慧玲, 林蜜, 邵婷. 三维球体间充质干细胞培养技术的研究进展及其应用[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 229-234.
[8] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[9] 任加发, 邬步云, 邢昌赢, 毛慧娟. 2022年急性肾损伤领域基础与临床研究进展[J]. 中华肾病研究电子杂志, 2023, 12(05): 276-281.
[10] 何彬, 王静. 彩色多普勒超声血流参数、血清尿酸、胱抑素C对短暂性脑缺血发作患者颈动脉狭窄的诊断价值[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 289-294.
[11] 张坤淇, 张睿, 徐佳, 康庆林. 漂浮膝损伤的诊治进展[J]. 中华老年骨科与康复电子杂志, 2023, 09(04): 252-256.
[12] 曹玲, 张业坡, 袁珊珊, 胡红杰, 余日胜. 恶性胆道梗阻行胆道支架置入术后危重并发症及其危险因素研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 203-210.
[13] 吴一菡, 雷章, 卢宏达. MUC16/CA125在良恶性肿瘤诊治中的作用及其研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(05): 591-595.
[14] 李秦鹏, 王其涛, 朱媛媛, 周琦, 刘笑言, 许勇. 颈动脉彩色多普勒超声、颈部CT血管成像及脑部CT灌注成像在脑梗死并发颈动脉狭窄患者中的应用研究[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 482-488.
[15] 杨洋, 闫盛, 陈作观, 吴志远, 刁永鹏, 高擎, 陈跃鑫, 郑月宏, 李拥军. 补片式颈动脉内膜剥脱术与外翻式颈动脉内膜剥脱术长期随访结果比较[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 337-343.
阅读次数
全文


摘要